Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CRBU
#3070
Caribou Biosciences, Inc. Common Stock
1.9
0
-1.55%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-1.55%
Changement Mensuel
+21.79%
Evolution sur 6 mois
-5.94%
Changement Annuel
+62.39%
Clôture Précédente
1.9
3
Open
1.9
0
Bid
Ask
Low
1.9
0
High
1.9
0
Volume
25
Marchés
Actions des Marchés US
Soins de Santé
CRBU
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
60.66 M
61.3 M
90.31 M
93 M
—
Valuation ratios
Enterprise value
674.99 M
346.85 M
451.89 M
131.58 M
485.86 M
Price to earnings ratio
—
-4.03
-4.04
-0.96
-3.61
Price to sales ratio
—
29.02
11.92
14.37
58.57
Price to cash flow ratio
—
4.42
4.41
1.04
4.22
Price to book ratio
—
1.34
1.12
0.57
1.05
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.15
0.27
0.24
0.48
0.65
Return on equity %
0.17
0.33
0.28
0.59
0.84
Return on invested capital %
445.36
461.56
417.75
680.35
—
Gross margin %
100
100
100
100
400
Operating margin %
697.84
768.17
336.63
1 667.16
6 816.98
EBITDA margin %
—
—
—
—
—
Net margin %
697.26
717.79
296.05
1 491.95
6 690.03
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
15.15
9.25
11.97
7.16
26.99
Inventory turnover
—
—
—
—
—
Asset turnover
0.02
0.03
0.09
0.03
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0
0
0
0
—
Long term debt to total equity ratio
0
0
0
0
—
Per share metrics
Operating cash flow per share
—
1.5
1.26
1.53
1.36
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
5.21
5.05
2.76
8.74
Net current asset value per share
—
4.28
4.59
2.43
8.51
Tangible book value per share
—
4.95
4.99
2.8
8.45
Working capital per share
—
3.82
4.21
2.09
7.25
Book value per share
—
4.95
4.99
2.8
8.45
Nouvelles
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates
La directrice juridique de Caribou Biosciences a vendu pour 13.598$ d’actions CRBU
Caribou Biosciences CLO sold $13,598 in CRBU stock
Le CTO de Caribou Biosciences Kelly vend pour 6.100$ d’actions
Caribou Biosciences CTO Kelly sells $6.1k in shares
La directrice médicale de Caribou Biosciences vend pour 2.100$ d’actions CRBU
Khan, CBO de Caribou Biosciences, vend pour 13.598$ d’actions
Caribou Biosciences CMO sells $2.1k in CRBU stock
Khan, Caribou Biosciences CBO, sells $13598 in stock
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates
Genomics Stocks That Deserve a Place in Your Portfolio in 2026
Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year?